124 related articles for article (PubMed ID: 9585710)
1. Effect of flumazenil in lactate-sensitive patients with panic disorder.
Ströhle A; Kellner M; Yassouridis A; Holsboer F; Wiedemann K
Am J Psychiatry; 1998 May; 155(5):610-2. PubMed ID: 9585710
[TBL] [Abstract][Full Text] [Related]
2. Behavioral, neuroendocrine, and cardiovascular response to flumazenil: no evidence for an altered benzodiazepine receptor sensitivity in panic disorder.
Ströhle A; Kellner M; Holsboer F; Wiedemann K
Biol Psychiatry; 1999 Feb; 45(3):321-6. PubMed ID: 10023509
[TBL] [Abstract][Full Text] [Related]
3. Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder.
Nutt DJ; Glue P; Lawson C; Wilson S
Arch Gen Psychiatry; 1990 Oct; 47(10):917-25. PubMed ID: 2171449
[TBL] [Abstract][Full Text] [Related]
4. Nonresponse of adrenocorticotropic hormone in first-ever lactate-induced panic attacks in healthy volunteers.
Kellner M; Wiedemann K
Arch Gen Psychiatry; 1998 Jan; 55(1):85-6. PubMed ID: 9435765
[No Abstract] [Full Text] [Related]
5. Possible role of atrial natriuretic hormone in pituitary-adrenocortical unresponsiveness in lactate-induced panic.
Kellner M; Herzog L; Yassouridis A; Holsboer F; Wiedemann K
Am J Psychiatry; 1995 Sep; 152(9):1365-7. PubMed ID: 7653695
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and neuroendocrine responses to sodium lactate infusion in subjects with posttraumatic stress disorder.
Jensen CF; Keller TW; Peskind ER; McFall ME; Veith RC; Martin D; Wilkinson CW; Raskind MA
Am J Psychiatry; 1997 Feb; 154(2):266-8. PubMed ID: 9016280
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic hormone in lactate-induced panic attacks: mode of release and endocrine and pathophysiological consequences.
Kellner M; Knaudt K; Jahn H; Holsboer F; Wiedemann K
J Psychiatr Res; 1998; 32(1):37-48. PubMed ID: 9693999
[TBL] [Abstract][Full Text] [Related]
8. Effect of chloride or glucose on the incidence of lactate-induced panic attacks.
George DT; Lindquist T; Nutt DJ; Ragan PW; Alim T; McFarlane V; Leviss J; Eckardt MJ; Linnoila M
Am J Psychiatry; 1995 May; 152(5):692-7. PubMed ID: 7726308
[TBL] [Abstract][Full Text] [Related]
9. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder.
Woods SW; Charney DS; Silver JM; Krystal JH; Heninger GR
Psychiatry Res; 1991 Feb; 36(2):115-27. PubMed ID: 1850142
[TBL] [Abstract][Full Text] [Related]
10. Flumazenil challenge in social phobia.
Coupland NJ; Bell C; Potokar JP; Dorkins E; Nutt DJ
Depress Anxiety; 2000; 11(1):27-30. PubMed ID: 10723632
[TBL] [Abstract][Full Text] [Related]
11. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
Ströhle A; Holsboer F; Rupprecht R
Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
[TBL] [Abstract][Full Text] [Related]
12. Prolactin but not ACTH increases during sodium lactate-induced panic attacks.
Otte C; Kellner M; Arlt J; Jahn H; Holsboer F; Wiedemann K
Psychiatry Res; 2002 Mar; 109(2):201-5. PubMed ID: 11927145
[TBL] [Abstract][Full Text] [Related]
13. Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users.
Bernik MA; Gorenstein C; Vieira Filho AH
J Psychopharmacol; 1998; 12(2):146-50. PubMed ID: 9694026
[TBL] [Abstract][Full Text] [Related]
14. Sodium lactate and hypertonic sodium chloride induce equivalent panic incidence, panic symptoms, and hypernatremia in panic disorder.
Peskind ER; Jensen CF; Pascualy M; Tsuang D; Cowley D; Martin DC; Wilkinson CW; Raskind MA
Biol Psychiatry; 1998 Nov; 44(10):1007-16. PubMed ID: 9821565
[TBL] [Abstract][Full Text] [Related]
15. Autonomic reactivity and hormonal secretion in lactate-induced panic attacks.
Seier FE; Kellner M; Yassouridis A; Heese R; Strian F; Wiedemann K
Am J Physiol; 1997 Jun; 272(6 Pt 2):H2630-8. PubMed ID: 9227540
[TBL] [Abstract][Full Text] [Related]
16. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: preliminary results.
Ströhle A; Romeo E; di Michele F; Pasini A; Hermann B; Gajewsky G; Holsboer F; Rupprecht R
Arch Gen Psychiatry; 2003 Feb; 60(2):161-8. PubMed ID: 12578433
[TBL] [Abstract][Full Text] [Related]
17. Effects of the benzodiazepine antagonist flumazenil in PTSD.
Randall PK; Bremner JD; Krystal JH; Nagy LM; Heninger GR; Nicolaou AL; Charney DS
Biol Psychiatry; 1995 Sep; 38(5):319-24. PubMed ID: 7495926
[TBL] [Abstract][Full Text] [Related]
18. Distinct panicogenic activity of sodium lactate and cholecystokinin tetrapeptide in patients with panic disorder.
Plag J; Gaudlitz K; Zschucke E; Yassouridis A; Pyrkosch L; Wittmann A; Holsboer F; Ströhle A
Curr Pharm Des; 2012; 18(35):5619-26. PubMed ID: 22632477
[TBL] [Abstract][Full Text] [Related]
19. Response to flumazenil in women with premenstrual dysphoric disorder.
Le Mellédo JM; Van Driel M; Coupland NJ; Lott P; Jhangri GS
Am J Psychiatry; 2000 May; 157(5):821-3. PubMed ID: 10784479
[TBL] [Abstract][Full Text] [Related]
20. Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder.
Molosh AI; Johnson PL; Fitz SD; Dimicco JA; Herman JP; Shekhar A
Neuropsychopharmacology; 2010 May; 35(6):1333-47. PubMed ID: 20130534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
